Ruben Mesa: Excited to be a co-investigator of the MANIFEST2 trial presented by Alessandro Vannucchi at EHA25

Ruben Mesa, President and Executive Director of Atrium Health Levine Cancer Institute and Atrium Health Wake Forest Baptist Comprehensive Cancer Center, shared a post on LinkedIn:

“Excited to be a co-investigator of the MANIFEST2 trial presented by Alessandro Vannucchi at EHA25. The 72-week data of the combination of Pelabresib plus Ruxolitinib showed durably superior responses for the combination for control of splenomegaly and dual responders.”